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DISPATCHES
Prosthetic vascular graft infections (PVGIs) of the thoracic aorta occur in 1%–3% of patients, 
but lethality rates are >20% (1,2). Because of an ag-
ing population with multiple medical conditions, 
more vascular grafts are being implanted, result-
ing in more PVGIs. Infection often occurs during 
the perioperative period (3) as a consequence of 
inoculation with bacteria mostly originating from 
the patient’s own skin flora. PVGIs are biofilm-as-
sociated infections in which the matrix around the 
bacteria impairs chances of treatment success (4). 
Hence, the primary aim is to prevent perioperative 
infections by identifying risk factors, such as type 
of prosthesis. 
The few comparative studies reported have fo-
cused mostly on use of antibiotic-bonded grafts to 
reduce the risk for PVGIs in vitro and in vivo (5–7). 
However, lack of approval by regulatory authorities, 
reduced commercial availability, and lack of long-
term follow-up data on infection-free survival should 
be considered (8–10). Furthermore, selection pressure 
from the use of topical antibiotics might lead to resis-
tance. Staphylococcus aureus has been shown to colo-
nize rifampin-bonded grafts 7 days after implanta-
tion (10). Hence, implanted grafts are usually coated 
with proteinaceous solutions only, allowing for quick 
integration into host tissue. We compared susceptibil-
ity of 2 graft materials to biofilm formation in vitro 
and rates of infections in vivo. 
For our in vitro study, we compared the suscep-
tibility of 2 thoracic vascular woven polyester grafts 
with different coatings—collagen (collagen graft, 
InterGard Hemabridge, https://www.getinge.com) 
and gelatin (gelatin graft, Terumo Aortic, Gelweave, 
https://terumoaortic.com)—to biofilm formation. 
The collagen graft is coated with a highly purified 
form of cross-linked bovine type 1 collagen. The 
gelatin graft is coated with a modified mammalian 
gelatin. Gelatin is derived mainly from type 1 col-
lagen by heat denaturation, a process during which 
collagen loses its native triple helical structure. The 
resorption time for collagen is 4–8 weeks and for gel-
atin, 14 days. For our in vivo study, we investigated 
the rate of infections associated with the 2 grafts 
among prospective patients undergoing open-chest 
cardiac surgery at the University Hospital Zurich 
(Zurich, Switzerland).
The Study
For the in vitro experiments, we dissected the grafts 
into 5 × 5 mm square pieces and inoculated them 
with bacterial strains representing pathogens impli-
cated in thoracic PVGI in our patient cohort. These 
were derived from either Vascular Graft Cohort 
Study (VASGRA) patients or laboratory strains (Ap-
pendix Table 1, Figure 1, https://wwwnc.cdc.gov/
EID/article/26/10/19-1711-App1.pdf) and main-
tained on Columbia blood agar plates (bioMérieux 
SA, https://www.biomerieux.com) and in tryptic 
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Prosthetic vascular graft infections of the thoracic aorta 
are rare but can be fatal. Our comparison of collagen- 
and gelatin-coated grafts showed that collagen-coated 
grafts were associated with increased biofilm formation 
and bacterial adherence in vitro and with higher rates of 
perioperative vascular graft infections in vivo. 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 26, No. 10, October 2020 2449
soy broth (Becton Dickinson, https://www.bd.com) 
at 37°C. Graft patches were incubated with bacteria 
in tryptic soy broth–glucose solution (glucose con-
centration 8 mmol/L) at 37°C for 72 h, and medium 
was exchanged every 24 h. The patches were washed 
with phosphate-buffered saline (PBS), sonicated at 44 
khz, and the resulting optical density at a wavelength 
of 600 was measured in a microplate reader. All bac-
teria, apart from Pseudomonas aeruginosa strain 2, 
showed increased biofilm formation on the collagen 
graft compared with the gelatin graft patches (Figure, 
panel A).
Biofilms of selected strains were stained with 
SYTO 9 of the LIVE/DEAD BacLight Bacterial Vi-
ability Kit (ThermoFisher Scientific, https://www.
thermofisher.com) according to the manufacturer’s 
instructions. The graft patches were placed in 8-well 
microslides (ibidi, https://ibidi.com) and visualized 
by confocal laser scanning microscopy with a Leica 
TCS SP8 inverted microscope (https://www.leica-
microsystems.com) under a 63×/1.4 oil immersion 
objective. We selected 2 representative spots per graft 
patch, providing a stack of horizontally acquired im-
ages (512 × 512 pixels representing an area of 244.8 
µm × 244.8 µm) with a z-step size of 0.12 µm. We pro-
cessed the obtained stacks by using Imaris 9.2.0 soft-
ware (Bitplane; Oxford Instruments, https://imaris.
oxinst.com/support/imaris-release-notes/9-2-0). 
Biofilm height and volume were determined as pre-
viously described (11). This approach illustrated the 
increased biofilm formation on collagen graft patches 
(Appendix Figure 2). Quantitative analysis from the 
obtained confocal laser scanning microscopy imag-
es corroborated the initial findings because biofilm 
grown on collagen graft patches displayed increased 
total biofilm mass volume as well as maximal biofilm 
height (Figure, panel B).
One possible explanation for the increased sus-
ceptibility to biofilm formation could be the distinct 
coatings of the grafts. Hence, we coated well plates 
overnight at 4°C with either rat tail collagen 1 (10 
µg/mL; ThermoFisher Scientific) or type B gelatin 
solution (10 µg/mL; Sigma-Aldrich, https://www.
sigmaaldrich.com). The plates were incubated with 
bacteria at 37°C for 30 min. Bacteria were washed, 
stained with 0.1% crystal violet (Fluka; Sigma Al-
drich, https://www.sigmaaldrich.com), solubilized 
in 95% ethanol, and the resulting optical density at 
570 nm was measured. The tested strains adhered 
substantially better to collagen (Figure, panel C). Our 
findings are supported by studies demonstrating the 
potential of gram-positive bacteria to adhere to col-
lagen, whereas only minor affinity was observed for 
gelatin (12,13).
To assess the effects of these findings in vivo, 
we analyzed 412 prospective participants with wo-
ven polyester grafts: 28 VASGRA participants in 
whom intracavitary thoracic PVGI developed and 
384 contemporaneous open-chest cardiac surgery 
patients in whom PVGI did not develop (controls) 
(Table). Data and strains isolated from patients 
were used in accordance with Cantonal Ethics Com-
mittee approval KEK-ZH-Nr. 2012-0583. For statis-
tical analyses with GraphPad Prism 8 (GraphPad 
Figure. Increased susceptibility of collagen graft to biofilm formation compared with gelatin graft. Graft patches were inoculated with 
indicated bacterial strains for 72 h and analyzed quantitatively and qualitatively. A) Biofilm formation on the graft patches determined by 
optical density measurements. B) Total biofilm mass volume and maximal biofilm height, respectively, formed on the graft patches by the 
3 clinical isolates—SA2, SE1, and EF— determined from the confocal laser scanning microscopy images with imaris software (https://
imaris.oxinst.com). C) Adherence assay to the 2 different coatings used by the grafts. The limit of reliable detection of the plate reader 
is indicated by the dashed line ( OD
600nm
 = 0.1). All data represent mean ± SD of 3 biological replicates performed in at least 2 technical 
replicates and were analyzed by using GraphPad Prism 8 (GraphPad Software, https://www.graphpad.com). The values above the 
graphs represent p values, calculated by using 2-way analysis of variance with the Sidak multiple comparison to determine statistical 
significance between the 2 graft types or coatings (panels A–C). EF, Enterococcus faecalis; OD
600nm
, optical density at a wavelength of 
600; PA, Pseudomonas aeruginosa; PM, Pasteurella multocida; PVGI, prosthetic vascular graft infection; SA, Staphylococcus aureus; 
SE, S. epidermidis.
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Software, https://www.graphpad.com), we used 
nonparametric tests (Fisher exact or Wilcoxon 
rank-sum, as appropriate). When normalized to the 
total number of control patients (n = 384 who had 
undergone the cardiac surgery but had no PVGI), 
the calculated percentage of intracavitary thoracic 
PVGI (n = 28 VASGRA patients who had under-
gone the cardiac surgery and had PVGI) was higher 
for patients in the collagen-graft (10.8%) versus the 
gelatin-graft group (3.52%; p<0.005).
Conclusions
We found more biofilm formation on collagen-
coated polyester vascular grafts than on gelatin-
coated grafts, possibly because the tested strains 
adhered substantially better to collagen than to 
 
Table. Risk for early and late intracavitary thoracic PVGI among cardiac surgery patients with vascular woven polyester grafts coated 
with collagen or gelatin, Zurich, Switzerland* 
Demographics and risk factors 
Early thoracic PVGI, 
n = 15 
Late thoracic PVGI, 
n = 13 
Cardiac surgery, 
no PVGI, n = 384 p value† 
Demographic     
 Sex    0.27 
  M 3 (20) 3 (23) 54 (14)  
  F 12 (80) 10 (77) 330 (86)  
 Caucasian race 15 (100) 12 (92) 375 (98) 0.51 
 Age, y, median (IQR) 65 (54–68) 65 (51–68) 58 (49–67) 0.89 
Risk factors     
 BMI, kg/m2, median (IQR) 27 (24–33) 26 (23–28) 26 (24–29) 0.97 
 Smoking    0.69 
  Never 6 (40) 6 (46) 150 (39)  
  Former/current 9 (60) 7 (54) 234 (61)  
 Alcohol consumption  4 (27) 3 (23) 131 (34.0) 0.41 
 Hypertension 12 (80) 8 (62) 273 (72) 1.0 
 Diabetes mellitus  2 (13) 1 (8) 54 (14) 0.78 
 Dyslipidemia  7 (47) 6 (46) 196 (51) 0.70 
 Cardiac events  8 (53) 7 (54) 173 (45) 0.43 
 Cerebrovascular events  3 (20) 3 (23) 58 (15) 0.41 
 Coagulopathy  0 (0) 0 (0) 4 (1.0) 1.0 
 Malignancy,  4 (27) 2 (15) 69 (18) 0.62 
 Charlson Comorbidity Index score, median (IQR) 2 (1–5) 2 (1–4) 1 (1–3) 0.27 
Index surgery    0.55 
 Dissection 7 (57) 6 (46) 154 (40)  
 Aneurysm/pseudoaneurysm 8 (53) 7 (54) 230 (60)  
 Symptoms at index operation    0.004 
  Asymptomatic 4 (27) 5 (23) 223 (58)  
  Symptomatic 9 (60) 10 (77) 161 (42)  
 Setting of index operation     0.08 
  Elective 9 (60) 7 (54) 284 (74)  
  Urgent/emergency 6 (40) 6 (46) 100 (26)  
 ASA class at index operation     <0.001 
  Grade <III 7 (47) 3 (23) 38 (10)  
  Grade >III 8 (53) 10 (77) 346 (90)  
 Cardiopulmonary bypass time, min, median (IQR) 174 (154–338) 163 (84–363) 206 (154–338) 0.23 
 Polyester vascular woven grafts    0.005 
  Collagen graft  11 (74) 9 (69) 165 (39.5)  
  Gelatin graft  4 (27) 4 (31) 219 (52.4)  
PVGI     
 Assumed route     NA 
  Perioperative 15 (100) 0 NA  
  Hematogenous 0 8 (62) NA  
  Contiguous 0 5 (38) NA  
 Microorganisms     NA 
  Staphylococcus aureus 4 (27) 3 (23) NA  
  Coagulase-negative staphylococci 2 (13) 1 (7.7) NA  
  Enterococcus faecalis 0 2 (15)   
  Streptococcus spp 4 (27) 0 NA  
  Cutibacterium acnes 1 (7) 2 (15) NA  
  Pseudomonas aeruginosa 1 (7) 0 NA  
  Pasteurella multocida 1 (7) 0 NA  
  Culture negative 2 (14) 3 (23) NA  
*Values are no. (%) unless otherwise indicated. ASA, American Society of Anesthesiology; BMI, body mass index; IQR, interquartile range; NA, not 
applicable; PVGI, prosthetic vascular graft infection. 
†p values from Fisher exact test (categorical variables) and Wilcoxon rank-sum test (continuous variables) comparing patients with PVGI (early and late 
combined) and patients without PVGI.  
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gelatin. When we analyzed prospective patients with 
PVGI and contemporary controls, the percentage 
of PVGI associated with collagen-coated grafts was 
also higher.
The strengths of our study include use of patient-
derived strains of bacteria and the prospective collec-
tion of patients with incident PVGIs and controls. Our 
study has some limitations. First, it was a single-cen-
ter study, resulting in low patient numbers, and the 
role of the graft material as a risk factor for PVGI is 
difficult to prove because of the rarity of the infection. 
Furthermore, data for patients with PVGI have to be 
interpreted with caution because some patients have 
additional foreign material in the heart. Second, pub-
licly available information on the exact type of coat-
ing as well as the application procedures used is lack-
ing. In addition, the experiments were performed in a 
static experimental setup instead of a flow chamber. 
However, because we were interested in direct bacte-
rial adherence to the graft material, simulating a sce-
nario in which infection would occur as consequence 
of unintentional inoculation during the perioperative 
period, we believe that the setup used is adequate. 
We did not reproduce a gram-positive and gram-neg-
ative mixed biofilm formation experiment because a 
monomicrobial setup enabled us to determine which 
material and coating was more susceptible to bacte-
rial adherence in a more controllable fashion.
In conclusion, biofilm formation was increased 
on collagen-coated vascular grafts compared with 
gelatin-coated grafts in vitro. As opposed to an-
other risk factor analysis from the VASGRA study 
(3), in our study, the graft material was associated 
with the PVGI rate. Parameters such as vasculariza-
tion potential, secure pseudointima growth, and 
reduced thrombogenicity are perceived as affecting 
successful integration and functionality of prosthet-
ic vascular grafts (14). Further parameters should 
be considered in the future design and develop-
ment of vascular prostheses to reduce the emerging 
trend of PVGI.
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Hoffmann, L. Husmann, D. Jaeger, R. Kopp,  
B. Ledergerber, C. A. Mestres, Z. Rancic, R. Zbinden, A. 
Zimmermann, A. S. Zinkernagel.
Acknowledgments
We are grateful to our patients for their participation in the 
study. We thank study nurses Caroline Mueller and  
Simone Bürgin, and we thank Christine Laich and  
Christine Voegtli for administrative assistance. 
Confocal imaging was performed with the support of the 
Center for Microscopy and Image Analysis, University of 
Zurich. Data included in this publication are part of a  
master thesis at the Faculty of Science, University of  
Zurich (T.A.S.).
This study was financed within the framework of 
VASGRA, supported by the Swiss National Science 
Foundation grant 320030_184918/1 (to B.H.) and 
31003A_176252 (to A.S.Z.). This work was also supported 
by the Clinical Research Priority Program of the University 
of Zurich for the Clinical Research Priority Program  
Precision Medicine for Bacterial Infections. The funders 
had no role in study design, data collection and analysis, 
decision to publish, or preparation of the manuscript.
B.H. and A.S.Z. designed the study. T.A.S. and S.M.S. 
performed the experiments, analyzed the data and wrote 
the first draft. All authors contributed to data collection 
and interpretation of the data, reviewed drafts of the 
manuscript, wrote the final version of the manuscript, and 
approved the final manuscript.
About the Author
Mr. Schweizer is a PhD student at the Department of  
Infectious Diseases and Hospital Epidemiology at the  
University Hospital of Zurich. His primary research  
interests include bacterial and fungal chronic infections as 
well as the resulting host–pathogen interactions.
References
  1. Hasse B, Husmann L, Zinkernagel A, Weber R, Lachat 
M, Mayer D. Vascular graft infections. Swiss Med Wkly. 
2013;143:w13754.
  2. Wilson WR, Bower TC, Creager MA, Amin-Hanjani S, 
O’Gara PT, Lockhart PB, et al. Vascular graft infections, 
mycotic aneurysms, and endovascular infections: a  
scientific statement from the American Heart Association. 
Circulation. 2016;134:e412–60. https://doi.org/10.1161/
CIR.0000000000000457
  3. Anagnostopoulos A, Ledergerber B, Kuster SP, Scherrer AU, 
Naf B, Greiner MA, et al. Inadequate perioperative prophy-
laxis and postsurgical complications after graft implantation 
are important risk factors for subsequent vascular graft  
infections – prospective results from the VASGRA  
cohort study. Clin Infect Dis. 2018;69:621–30.  
https://doi.org/10.1093/cid/ciy956
  4. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, 
Dasgupta M, et al. Bacterial biofilms in nature and disease. 
Annu Rev Microbiol. 1987;41:435–64. https://doi.org/ 
10.1146/annurev.mi.41.100187.002251
  5. Aboshady I, Raad I, Vela D, Hassan M, Aboshady Y, Safi HJ, 
et al. Prevention of perioperative vascular prosthetic  
infection with a novel triple antimicrobial-bonded  
arterial graft. J Vasc Surg. 2016;64:1805–14. https://doi.org/ 
10.1016/j.jvs.2015.09.061
  6. Osińska-Jaroszuk M, Ginalska G, Belcarz A, Uryniak A. 
Vascular prostheses with covalently bound gentamicin and 
Polyester Vascular Graft Material
DISPATCHES
2452 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 26, No. 10, October 2020
amikacin reveal superior antibacterial properties than  
silver-impregnated ones—an in vitro study. Eur J Vasc  
Endovasc Surg. 2009;38:697–706. https://doi.org/10.1016/ 
j.ejvs.2009.09.003
  7. Ricco JB, Assadian A, Schneider F, Assadian O. In vitro  
evaluation of the antimicrobial efficacy of a new  
silver-triclosan vs a silver collagen-coated polyester vascular 
graft against methicillin-resistant Staphylococcus aureus.  
J Vasc Surg. 2012;55:823–9. https://doi.org/10.1016/ 
j.jvs.2011.08.015
  8. Berard X, Stecken L, Pinaquy JB, Cazanave C, Puges M, 
Pereyre S, et al. Comparison of the antimicrobial  
properties of silver impregnated vascular grafts with and 
without triclosan. Eur J Vasc Endovasc Surg. 2016;51:285–92. 
https://doi.org/10.1016/j.ejvs.2015.10.016
  9. Goëau-Brissonnière OA, Fabre D, Leflon-Guibout V,  
Di Centa I, Nicolas-Chanoine M-H, Coggia M. Comparison 
of the resistance to infection of rifampin-bonded gelatin-
sealed and silver/collagen-coated polyester prostheses.  
J Vasc Surg. 2002;35:1260–3. https://doi.org/10.1016/ 
S0741-5214(02)67047-8
10. Schmacht D, Armstrong P, Johnson B, Pierre K, Back 
M, Honeyman A, et al. Graft infectivity of rifampin and 
silver-bonded polyester grafts to MRSA contamination. 
Vasc Endovascular Surg. 2005;39:411–20. https://doi.org/ 
10.1177/153857440503900505
11. Turonova H, Briandet R, Rodrigues R, Hernould M,  
Hayek N, Stintzi A, et al. Biofilm spatial organization by 
the emerging pathogen Campylobacter jejuni: comparison 
between NCTC 11168 and 81-176 strains under microaerobic 
and oxygen-enriched conditions. Front Microbiol. 2015;6:709. 
https://doi.org/10.3389/fmicb.2015.00709
12. Carret G, Emonard H, Fardel G, Druguet M, Herbage D, 
Flandrois JP. Gelatin and collagen binding to Staphylococcus  
aureus strains. Ann Inst Pasteur Microbiol (1985). 1985; 
136A:241–5. https://doi.org/10.1016/S0769-2609(85)80063-6
13. Elasri MO, Thomas JR, Skinner RA, Blevins JS,  
Beenken KE, Nelson CL, et al. Staphylococcus aureus collagen 
adhesin contributes to the pathogenesis of osteomyelitis. 
Bone. 2002;30:275–80. https://doi.org/10.1016/ 
S8756-3282(01)00632-9
14. Drury JK, Ashton TR, Cunningham JD, Maini R,  
Pollock JG. Experimental and clinical experience with a 
gelatin impregnated Dacron prosthesis. Ann Vasc Surg. 
1987;1:542–7. https://doi.org/10.1016/S0890-5096 
(06)61437-4
Address for correspondence: Barbara Hasse, Department of 
Infectious Diseases and Hospital Epidemiology, University 
Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland; 
email: barbara.hasse@usz.ch
EID Podcast
Tickborne Ehrlichia in North Carolina 
Visit our website to listen:
https://go.usa.gov/xy6UH
While caring for patients in North Carolina,  
Dr. Ross Boyce began to suspect that tickborne  
Ehrlichia was being underdiagnosed. His study  
showed that Ehrlichia, despite being relatively  
common, was only tested for in about a third of  
patients thought to have a tickborne illness. 
In this EID podcast, Dr. Ross Boyce, an infectious  
disease physician at the University of North Carolina  
at Chapel Hill, examines the prevalence and  
diagnosis of Ehrlichia in North Carolina. 
